Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N014614 |
| CAS No | NA |
| Mol.F. | C26H28N4O7 |
| Mol.Wt. | 508.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014615 |
| CAS No | NA |
| Mol.F. | C23H31N7O5S |
| Mol.Wt. | 517.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014616 |
| CAS No | NA |
| Mol.F. | C22H23ClF4N8O3 |
| Mol.Wt. | 558.9 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014617 |
| CAS No | NA |
| Mol.F. | C20H28N6O4 |
| Mol.Wt. | 416.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014618 |
| CAS No | 2925306-68-7 |
| Mol.F. | C28H21F3N8O2 |
| Mol.Wt. | 558.5 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N014619 |
| CAS No | NA |
| Mol.F. | C21H25N3O8 |
| Mol.Wt. | 447.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014620 |
| CAS No | NA |
| Mol.F. | C24H27N9O4 |
| Mol.Wt. | 505.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014621 |
| CAS No | NA |
| Mol.F. | C31H32N6O5 |
| Mol.Wt. | 568.63 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014622 |
| CAS No | NA |
| Mol.F. | C16H14F2N4O5S |
| Mol.Wt. | 412.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014623 |
| CAS No | NA |
| Mol.F. | C11H14ClN5O3 |
| Mol.Wt. | 299.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014624 |
| CAS No | NA |
| Mol.F. | C10H14N6O4 |
| Mol.Wt. | 282.26 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014625 |
| CAS No | NA |
| Mol.F. | C21H22N8O3S |
| Mol.Wt. | 466.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014626 |
| CAS No | 70-25-7 |
| Mol.F. | C2H5N5O3 |
| Mol.Wt. | 147.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014627 |
| CAS No | 1233340-45-8 |
| Mol.F. | C3H3N3O |
| Mol.Wt. | 97.1 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014628 |
| CAS No | NA |
| Mol.F. | C28H26ClN3O8 |
| Mol.Wt. | 568.0 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N014629 |
| CAS No | NA |
| Mol.F. | C29H31ClN4O8 |
| Mol.Wt. | 599.0 |
| INV STATUS | CUSTOM SYNTHESIS |